Clinical Trials Directory

Trials / Unknown

UnknownNCT02176109

Metabolism Des LAM

Rôle Pronostique Des métabolismes du Stress Oxydatif et du Fer Dans Les Leucémies Aiguës Myéloblastiques

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
University Hospital, Grenoble · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In this study, the investigators study the prognostic role of oxidative stress metabolism and iron in Acute myeloid leukemia.

Detailed description

Primary goal of this study is to Evaluate the characteristics of regulatory networks of iron and redox balance in leukemic cells, to study the correlations between the prognosis of AML patients (in terms of response to induction chemotherapy and survival i) and metabolism of these markers. Secondary ones areto assess the impact of induction therapy on markers of oxidative stress and to correlate biological iron and redox metabolism with the molecular status of patients (eg Flt3/IDH/CEBPA/NPM...). Eligibility criteria are patients at diagnostic of de novo acute myeloid leukemia (promyelocytic excluded) aged from 18 to 100 years.

Conditions

Timeline

Start date
2013-06-01
Primary completion
2015-06-01
Completion
2018-06-01
First posted
2014-06-26
Last updated
2014-06-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02176109. Inclusion in this directory is not an endorsement.